RTSL (Rapid Therapeutic Science Laboratories) Treasury Stock: $-0.34 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rapid Therapeutic Science Laboratories Treasury Stock?

Rapid Therapeutic Science Laboratories RTSL Treasury Stock is $-0.34 Mil as of Jun. 2023.

Treasury stock is the portion of shares that a company keeps in their own treasury. Rapid Therapeutic Science Laboratories's treasury stock for the quarter that ended in Jun. 2023 was $-0.34 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Rapid Therapeutic Science Laboratories Treasury Stock Historical Data

* Premium members only.

The historical data trend for Rapid Therapeutic Science Laboratories's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Therapeutic Science Laboratories Treasury Stock Chart

Rapid Therapeutic Science Laboratories Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Dec21 Dec22
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.34 -0.34 -0.34 -0.34 -0.34

Rapid Therapeutic Science Laboratories Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.34 -0.34 -0.34 -0.34 -0.34

Rapid Therapeutic Science Laboratories Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of $-0.34 Mil mean?
Rapid Therapeutic Science Laboratories (RTSL) has a Treasury Stock of $-0.34 Mil as of Jun. 2023. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Rapid Therapeutic Science Laboratories and its competitors.
Is Rapid Therapeutic Science Laboratories' Treasury Stock too high?
Rapid Therapeutic Science Laboratories' current Treasury Stock is $-0.34 Mil.
How does Rapid Therapeutic Science Laboratories' Treasury Stock compare to VRAYQ and NNMX?
Rapid Therapeutic Science Laboratories' Treasury Stock of $-0.34 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Diversified Financial Services company?
A good Treasury Stock depends on the Diversified Financial Services industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Rapid Therapeutic Science Laboratories and its competitors. Rapid Therapeutic Science Laboratories's current Treasury Stock is $-0.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rapid Therapeutic Science Laboratories stock overvalued right now?
Rapid Therapeutic Science Laboratories (RTSL) has a current Treasury Stock of $-0.34 Mil. The current Treasury Stock is $-0.34 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Rapid Therapeutic Science Laboratories (RTSL), the current Treasury Stock is $-0.34 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rapid Therapeutic Science Laboratories Business Description

Address 558 County Road 472, De Leon, TX, USA, 76444
Rapid Therapeutic Science Laboratories Inc currently has no operations and operates as a blank check company.